CTLA-4 +49A>G polymorphism is associated with advanced non-small cell lung cancer prognosis.
about
The effect of lysyl oxidase polymorphism on susceptibility and prognosis of nonsmall cell lung cancerPD-1 gene promoter polymorphisms correlate with a poor prognosis in non-small cell lung cancerLysyl oxidase polymorphisms and susceptibility to osteosarcoma.Cytotoxic T lymphocyte-associated antigen-4 +49A>G polymorphism and the risk of non-small cell lung cancer in a Chinese populationThe prognostic value of cytotoxic T-lymphocyte antigen 4 in cancers: a systematic review and meta-analysis.Polymorphisms of co-inhibitory molecules (CTLA-4/PD-1/PD-L1) and the risk of non-small cell lung cancer in a Chinese populationCtla-4 expression and polymorphisms in lung tissue of patients with diagnosed non-small-cell lung cancer.Rationale for targeting the immune system through checkpoint molecule blockade in the treatment of non-small-cell lung cancer.The hypoxic tumor microenvironment: driving the tumorigenesis of non-small-cell lung cancer.Investigation of Cytotoxic T-lymphocyte antigen-4 polymorphisms in non-small cell lung cancer: a case-control study.Association between cytotoxic T lymphocyte antigen-4 +49A/G, -1722T/C, and -1661A/G polymorphisms and cancer risk: a meta-analysis.CTLA-4 polymorphisms are associated with treatment outcomes of patients with multiple myeloma receiving bortezomib-based regimens.Lysyl oxidase genetic variants and the prognosis of glioma.Association between the cytotoxic T-lymphocyte antigen 4 +49A/G polymorphism and bladder cancer risk
P2860
Q28274238-A742FADF-EE8F-4643-BCAC-FB4A76ED8D5CQ34265875-2410434E-7A36-445B-A552-D92EA3A0E947Q34388063-C06F1423-51AD-485C-BA5E-F15D4EFA6CB5Q36046801-BECCB7D8-330F-42D1-B3A2-AE47609C7D70Q36283876-D71212E3-405C-4CDB-A84B-D4DC1EFE60CCQ36318092-84F6F091-E8E1-42F7-8860-D90491F1083DQ37044252-D81D4604-1A23-4A55-B299-A61E128BE2D6Q38080047-3F469F06-9D05-4ABD-8EE8-D20BE2DCE2E5Q38296670-64BAA272-9358-4A9D-A0C2-7F9E2FE767BCQ43278116-60F889A4-72EE-4871-8A39-C94786C5A528Q45395844-4326E951-732F-4F6A-8AD4-8E308F9E6B35Q47267543-063B4250-A026-45B5-AC13-18E1C462AFD4Q50916015-5DB842C5-8212-4593-9367-8D21A79447DAQ56897093-0BC7632F-0649-48F2-8269-B197734C15C5
P2860
CTLA-4 +49A>G polymorphism is associated with advanced non-small cell lung cancer prognosis.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
CTLA-4 +49A>G polymorphism is ...... ll cell lung cancer prognosis.
@ast
CTLA-4 +49A>G polymorphism is ...... ll cell lung cancer prognosis.
@en
CTLA-4 +49A>G polymorphism is ...... ll cell lung cancer prognosis.
@nl
type
label
CTLA-4 +49A>G polymorphism is ...... ll cell lung cancer prognosis.
@ast
CTLA-4 +49A>G polymorphism is ...... ll cell lung cancer prognosis.
@en
CTLA-4 +49A>G polymorphism is ...... ll cell lung cancer prognosis.
@nl
prefLabel
CTLA-4 +49A>G polymorphism is ...... ll cell lung cancer prognosis.
@ast
CTLA-4 +49A>G polymorphism is ...... ll cell lung cancer prognosis.
@en
CTLA-4 +49A>G polymorphism is ...... ll cell lung cancer prognosis.
@nl
P2093
P2860
P356
P1433
P1476
CTLA-4 +49A>G polymorphism is ...... ll cell lung cancer prognosis.
@en
P2093
Jinxiang Han
Mingyu Wang
Xianrang Song
Yanbing Liu
Yufang Zhu
Zhehai Wang
P2860
P304
P356
10.1159/000329345
P577
2011-08-11T00:00:00Z